Use

This Real‑Time Quantitative (Reverse Transcription Polymerase Chain Reaction) assay amplifies the CBFB/MYH11 fusion transcript to detect the chromosome inversion inv(16) or translocation t(16;16) commonly associated with Acute Myeloid Leukemia (AML). It can be utilized for minimal residual disease (MRD) monitoring and to assess relapse risk in patients with inv(16)/t(16;16) AML.